BIO 2021 Notebook: A Breakthrough Year For Emerging Companies?

 
• By Scrip Team and Pink Sheet Team
  
BIO 2021 Notebook - Day 2
BIO included updates on the Reagan-Udall RWE accelerator project and the need to put digital product data into context for stakeholders.

More from Drug Pricing

More from Scrip